CAR T-Cell therapy: Bambino Gesù trial and broadening treatment in Europe
This recorded session from Solving Kids’ Cancer UK’s 2026 Neuroblastoma Parent Symposium explores the Bambino Gesù CAR T-cell trial for relapsed and refractory neuroblastoma, including its expansion across European treatment centres and ongoing efforts to broaden access to CAR T therapy. The session also includes a parent perspective on travelling abroad for treatment and navigating the challenges of accessing innovative therapies.
Looking for something else?
-
Need to speak with someone?Get in touch with our Family Support Team.
-
Help and supportHead to our Help and Support homepage to see how we can support you.
-
Relapsed neuroblastomaFind all the information on relapsed neuroblastoma in one place.
-
Refractory neuroblastomaFind all the information on refractory neuroblastoma in one place.
Related videos
-
VideoBEACON2
Learn about the BEACON2 trial for relapsed neuroblastoma, including its aims and potential side effects.
-
VideoThe MINT study
A simple overview of the MINT study and new approaches being explored for treating high‑risk neuroblastoma.
-
VideoTreating relapsed and refractory disease
An overview of clinical trials and new treatments for relapsed and refractory neuroblastoma.